These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3371082)

  • 1. Haemorheological effects of fructose-1,6-diphosphate in patients with lower extremity ischaemia.
    Cacioli D; Clivati A; Pelosi P; Megevand J; Galeone M
    Curr Med Res Opin; 1988; 10(10):668-74. PubMed ID: 3371082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL; Zheng Q; Worthy SA; Charles B; Bradley DV
    Angiology; 2002; 53(5):509-20. PubMed ID: 12365857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic and haemorheological effects of buflomedil in patients with peripheral occlusive arterial disease.
    Perego MA; Sergio G; Espureo M; Francisci A; Artale F
    Curr Med Res Opin; 1982; 8(3):178-87. PubMed ID: 7128189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of the flow properties of blood: a new therapeutical approach in occlusive arterial disease.
    Ehrly AM
    Angiology; 1976 Mar; 27(3):188-96. PubMed ID: 1078314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of n-3 fatty acids on blood rheology.
    Ernst E
    J Intern Med Suppl; 1989; 731():129-32. PubMed ID: 2539829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of intravenous infusions of hydroxyethylstarch (HES) (MW 40,000 and 450,000) on the blood flow properties of healthy volunteers.
    Ehrly AM; Landgraf H
    Angiology; 1985 Jan; 36(1):41-4. PubMed ID: 2411169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fructose-1,6-diphosphate on the red cell deformability in diabetic patients.
    Marsilii A; Petruzzi E; Di Noto C; Marini P
    Agressologie; 1984 Sep; 25(8):919-21. PubMed ID: 6507765
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of carvedilol on common carotid arterial flow, peripheral hemodynamics, and hemorheologic variables in hypertension.
    Nagakawa Y; Akedo Y; Kaku S; Orimo H
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S115-9. PubMed ID: 1974500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute carbon monoxide poisoning alters hemorheological parameters in human.
    Ozturk B; Arihan O; Coskun F; Dikmenoglu-Falkmarken NH
    Clin Hemorheol Microcirc; 2016; 61(4):591-7. PubMed ID: 25536918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood flow properties and walking performance in chronic arterial occlusive disease.
    Angelkort B; Spürk P; Habbaba A; Mähder M
    Angiology; 1985 May; 36(5):285-92. PubMed ID: 3896044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of fructose-1,6-diphosphate and trental on the erythrocyte aggregating capacity in ischemic heart disease].
    Badalian GO; Episkoposian NG; Amatuni GV
    Ter Arkh; 1987; 59(7):92-5. PubMed ID: 3672368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral acrylamide intake on blood viscosity parameters in rats.
    Arıhan O; Seringeç NB; Gürel Eİ; Dikmenoğlu NH
    Clin Hemorheol Microcirc; 2011; 47(1):45-52. PubMed ID: 21321407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemorheological effects of secoisolariciresinol in ovariectomized rats.
    Maslov MY; Plotnikova TM; Anishchenko AM; Aliev OI; Nifantiev NE; Plotnikov MB
    Biorheology; 2016 Jan; 53(1):23-31. PubMed ID: 26756280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemorheological changes in uraemic children in response to erythropoietin treatment.
    Böhler T; Leo A; Linderkamp O; Braun A; Schärer K
    Nephrol Dial Transplant; 1993; 8(2):140-5. PubMed ID: 8384334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lovastatin alters blood rheology in primary hyperlipoproteinemia: dependence on lipoprotein(a)?
    Koenig W; Hehr R; Ditschuneit HH; Kuhn K; Ernst E; Rosenthal J; Hombach V
    J Clin Pharmacol; 1992 Jun; 32(6):539-45. PubMed ID: 1634641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fructose-1,6-diphosphate in the treatment of chronic heart failure].
    Sun JP; Zhi G; Yang XS
    Zhonghua Nei Ke Za Zhi; 1989 May; 28(5):274-6, 314. PubMed ID: 2805965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of an infusion of piribedil in normal subjects and in patients with peripheral obliterating arterial disease on the blood flow of the lower limbs and on blood, plasma and serum viscosity].
    Forconi S; Guerrini M; Agnusdei D; Di Perri T
    Minerva Med; 1976 May; 67(25):1671-80. PubMed ID: 934519
    [No Abstract]   [Full Text] [Related]  

  • 18. A haemorheological study of lignocaine.
    Orr JE; Lowe GD; Nimmo WS; Watson R; Forbes CD
    Br J Anaesth; 1986 Mar; 58(3):306-9. PubMed ID: 3947492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemorheological improvement after Daflon 500 mg treatment in diabetes.
    Lacombe C; Bucherer C; Lelievre JC
    Int Angiol; 1988; 7(2 Suppl):21-4. PubMed ID: 3183453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First results obtained with fructose-1, 6-diphosphate (FDP) in the "hyperinsulinaemia" (excessive insulin release).
    Avogaro P; Bon GB; Pais M
    Pharmacol Res Commun; 1979 Feb; 11(2):121-32. PubMed ID: 375246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.